Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Companhia de saneamento Basico Do Estado De Sao Paulo - Sabesp American Depositary Shares (Each repstg 250 Common Shares) (SBS) vs GeneDx Holdings Corp (WGS) Price & Performance

Companhia de saneamento Basico Do Estado De Sao Paulo - Sabesp American Depositary Shares (Each repstg 250 Common Shares)Trade
GeneDx Holdings CorpTrade

Price performance (Past 24H)

Key statistics

Companhia de saneamento Basico Do Estado De Sao Paulo - Sabesp American Depositary Shares (Each repstg 250 Common Shares) vs GeneDx Holdings Corp — how do they compare? Companhia de saneamento Basico Do Estado De Sao Paulo - Sabesp American Depositary Shares (Each repstg 250 Common Shares) trades at $6.74 (market cap $23.36B), while GeneDx Holdings Corp trades at $67.33 (market cap $2.02B). The key difference: Companhia de saneamento Basico Do Estado De Sao Paulo - Sabesp American Depositary Shares (Each repstg 250 Common Shares) is far larger — about 11.6× GeneDx Holdings Corp's market cap, and Companhia de saneamento Basico Do Estado De Sao Paulo - Sabesp American Depositary Shares (Each repstg 250 Common Shares) pays a 0.51% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.

SBSWGS
Market Cap
$23.36B$2.02B
Volume
17,617,579734,640
Sector
UtilitiesHealth
52-Week High
$7.08$167.51
52-Week Low
$4.45$34.51
Enterprise Value
$30.17B$2.05B
Dividend Yield
0.51%—
Typical Hold Time
—19 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Companhia de saneamento Basico Do Estado De Sao Paulo - Sabesp American Depositary Shares (Each repstg 250 Common Shares)

No Aura AI signal available yet.

GeneDx Holdings Corp

GeneDx (WGS) trades at $67.73, down 1.17% with bearish technical signals despite recent earnings beats. The company shows strong revenue growth to $454M in 2026 but faces profitability challenges with a -23.4% net margin. Recent developments include new genomic testing products and hospital partnerships, while analyst consensus remains strongly bullish with a $81 price target.

The stock presents a growth story with expanding genomic testing volumes but carries significant execution risk given negative profitability metrics. Upside potential exists if management can translate revenue growth into sustainable profits, though current cash flow trends and high valuation multiples warrant caution for risk-averse investors.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

SBS

No sentiment data available yet.

WGS
100% Buy0% Sell
Avg holding period · 19 Days

About Companhia de saneamento Basico Do Estado De Sao Paulo - Sabesp American Depositary Shares (Each repstg 250 Common Shares)

Sabesp provides water supply and sewage services in the Brazilian state of São Paulo. Its shares trade in Brazil as SBSP3 and in the U.S. as NYSE-listed ADSs under SBS.

Read more on SBS →

About GeneDx Holdings Corp

GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.

Read more on WGS →